Recession in 2026? Here's My Take (and a 9% Payer to Profit)

The author recommends buying the Liberty All‑Star Growth Fund (ASG), highlighting a 9.8% market discount to NAV, a roughly 9% market yield (8.1% when measured against NAV), and a decade‑long NAV annualized return of 11.5% (≈12% over the last three years). With top holdings in US blue‑chip tech names (NVDA, MSFT, AAPL) and domestic midcaps (FSV, OLLI), plus macro tailwinds—Q3 GDP +4.4% and the Atlanta Fed’s GDPNow >5% for Q4—the thesis is that persistent NAV outperformance should narrow the discount and support dividend stability, making ASG an attractive yield‑oriented buy for portfolios.

Analysis

Market structure: The action concentrates gains in large-cap, AI-exposed names (NVDA, MSFT, AAPL) and vehicles that hold them (ASG), while fixed-income and unloved CEFs face persistent selling that depresses discounts. The ASG 9–10% market discount signals excess supply of CEF shares or distribution-driven selling rather than NAV weakness—you effectively buy US blue‑chip exposure at ~90c. Cross-asset: stronger GDP/AI narrative supports risk assets and USD; expect downward pressure on long-duration Treasuries if growth surprises persist, higher equity option IV around NVDA, and commodity/energy upside from capex cycles in semiconductors.

Risk assessment: Tail risks include regulatory crackdowns on AI, a sharp NVDA earnings miss, or a regime shock that forces Fed tightening—each could widen CEF discounts by 300–500bp in 1–3 months. Immediate (days) risk: headline-driven IV spikes; short-term (weeks–months): discount mean reversion or further widening depending on flows; long-term (quarters–years): secular AI adoption should support NAV growth but not guarantee P/NAV tightening. Hidden dependency: ASG pays relative to NAV (8% target), so market price yield can mask sustainability; retail redemptions or manager policy changes are second-order threats.

Trade implications: Direct long ASG at current discount with a covered-call overlay to capture 9%+ yield is attractive if you expect discount to compress to ~4–5% in 6–12 months (implying 10–20% total return including dividends). Tactical overweight NVDA/MSFT (small sizes) funded by trimming duration-sensitive bonds; implement a dollar-neutral pair: long ASG / short SPY to isolate discount convergence risk. Options: sell 30–60d OTM calls on ASG to boost income; buy 3–6m 10–15% OTM NVDA calls as event-driven asymmetric upside.

Contrarian angles: Consensus assumes the discount is temporary—but structural investor base changes could keep discounts wider for 1–3 years (historical CEF cycles show multi-year dislocations). Mispricing exists if you underwrite NAV coverage of dividends (ASG’s 8% NAV policy) and flow reversal catalysts (Fed pause, NVDA beat) arrive; conversely, overexposure to AI mega-cap concentration risks sector-specific drawdowns. Define objective triggers (discount <5% or NAV drawdown >8%) to harvest gains or cut exposure.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Liberty All‑Star Growth Fund (ASG) at current ~9–10% discount; target total return 15–20% within 6–12 months if discount compresses to ~4–5% plus dividends. Use a 12% trailing stop or cut if ASG NAV falls >5% over any 90‑day window.
• Implement a covered‑call overlay on ASG: sell 30–60 day OTM calls ~6–8% above market to boost yield to ~10–12% annually; roll monthly and cap uncovered exposure to 50% of the ASG position.
• Overweight NVDA (0.5–1.5% portfolio) and MSFT (0.5–1.0%) funded by trimming core bond exposure by 3–5% (or reducing IG duration by ~0.5 years); exit or reduce if NVDA implied vol >40% pre-earnings or if NVDA guidance misses by >10% revenue/GP margin miss.
• Execute a dollar‑neutral pair trade: long ASG / short SPY at equal notional (size 1–2% net exposure) to isolate CEF discount convergence; target spread capture of >7% in 6–12 months, stop if spread widens by >200bp.